Related Articles
Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib
Proliferation of sphere‑forming hepatocellular carcinoma cells is suppressed in a medium without glucose and arginine, but with galactose and ornithine
The growth inhibition of hepatocellular and cholangiocellular carcinoma cells by gemcitabine and the roles of extracellular signal-regulated and checkpoint kinases
2‑Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells
GSTM3 reverses the resistance of hepatoma cells to radiation by regulating the expression of cell cycle/apoptosis‑related molecules